INBS Profile
Intelligent Bio Solutions Inc. is a life sciences company focused on developing innovative, non-invasive diagnostic and monitoring solutions aimed at enhancing patient care. The company specializes in real-time diagnostic tests designed for both patients and healthcare providers, leveraging advanced biosensor technology to deliver actionable health insights. One of its notable products, the Saliva Glucose Biosensor, utilizes an organic thin-film transistor to measure glucose levels in saliva, providing a convenient and non-invasive alternative for diabetes management. This device aims to improve patient compliance and glucose monitoring efficiency without the need for blood samples.
In addition to its work in diabetes management, Intelligent Bio Solutions is developing a SARS-CoV-2 Biosensor, which is designed to complement existing RNA virus detection tests. This biosensor will enhance the accuracy and accessibility of COVID-19 diagnostics, providing rapid results that are crucial for effective pandemic management. The company's biosensor platform also extends to a wide array of diagnostic modalities, including biochemistry, immunology, tumor markers, hormones, and nucleic acids, reflecting its commitment to addressing diverse diagnostic needs through a single, integrated platform.
The company's research and development efforts are underpinned by its focus on creating versatile and user-friendly diagnostic tools. By combining advanced biosensor technology with a comprehensive diagnostic approach, Intelligent Bio Solutions aims to offer solutions that are not only innovative but also practical for routine clinical use. This approach positions the company at the forefront of the life sciences industry, addressing critical gaps in non-invasive testing and real-time health monitoring.
Formerly known as GBS Inc., Intelligent Bio Solutions rebranded in October 2022 to better align with its expanded focus and technological advancements. Established in 2016 and headquartered in New York, the company operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd. Its evolving portfolio and strategic direction underscore its dedication to advancing healthcare diagnostics and improving patient outcomes through cutting-edge biosensor technology.
|
